• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Edwards Lifesciences buys Embrella Cardiovascular for $43 million

Edwards Lifesciences buys Embrella Cardiovascular for $43 million

March 14, 2011 By MassDevice staff

EW

Edwards Lifesciences Inc. (NYSE:EW) scooped up Embrella Cardiovascular for a cool $43 million.

Wayne, Pa.-based Embrella makes embolic protection devices used in coronary procedures such as transcatheter valve replacements. Edwards officials said the deal, which closed March 11, will bolster the company’s position in the hot transcatheter valve market.

The Embrella embolic deflector system received the CE Mark in Europe in May 2010. The device is “placed in the aorta through a sheath inserted in the right brachial or right radial artery. Its porous membrane allows blood flow to the brain while simultaneously deflecting embolic material,” according to a press release.

Listen to our podcast with Edwards CEO Michael Mussallem

Edwards has had its eyes on Embrella for at least two years. Embrella launched in late 2007 and raised just under $9 million in two funding rounds. The latest, a Series B round of $6.7 million, closed in August 2009. Edwards was an investor in that round, which was led by BioStar Ventures and the MedFocus Fund. Hatteras Venture Partners also participated in the round.

Embrella is led by industry veteran Jeffrey O’Donnell, who was CEO of PhotoMedex for 10 years before joining Embrella in 2009.

Edwards, which also maintained its earnings guidance of between $1.59 billion to $1.67 billion in sales for 2011, said recently that it plans to be an active acquirer of new technology this year.

“We plan to invest aggressively in our future. We’re going to be substantially increasing our R&D by 20 percent [in 2011] and we plan to continue to be a long-term investor,” CEO Michael Mussallem told MassDevice in an early January interview.

Edwards is aiming for a US launch of its Sapien transcatheter valve replacement this fall.

Filed Under: Mergers & Acquisitions, News Well, Replacement Heart Valves Tagged With: Edwards Lifesciences

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy